Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 20 Jun 2025

USFDA approves first HIV prevention shot needing only two doses a year

Business Standard

Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution and near-complete protection to boost global HIV prevention efforts

Pharmaceuticals & Biotech.

SECTOR | 12 Jun 2025

More than 460 laid-off CDC employees receive reinstatement notices

Business Standard

More than 460 laid-off employees at the nation's top public health agency received notices on Wednesday that they are being reinstated, according to a union representing the workers. The US Department of Health and Human Services confirmed reinstatement notices went out to the former Centres for Disease Control and Prevention employees, but provided few details. About 2,400 CDC employees lost their jobs in a wave of cuts across federal health agencies in early April, according to a tally at the time. Whole CDC programmes were essentially shut down, including some focused on smoking, lead poisoning, gun violence, asthma and air quality, and workplace safety and health. The entire office that handles Freedom of Information Act requests was shuttered. Infectious disease programmes took a hit, too, including programmes that fight outbreaks in other countries, labs focused on HIV and hepatitis in the US, and staff trying to eliminate tuberculosis. An estimated 200 of the reinstated work

Pharmaceuticals & Biotech.

SECTOR | 09 Jun 2025

Glenmark set to launch blood cancer treatment drug Brukinsa in India

Business Standard

Glenmark will introduce Brukinsa, a BTK inhibitor developed by BeOne Medicines, in India after DCGI approval to treat five B-cell blood cancers with proven safety and efficacy

Glenmark Pharmaceuticals poised to launch Zanubrutinib in India

Business Line | 09 Jun 2025

Pharmaceuticals & Biotech.

SECTOR | 06 Jun 2025

Bayer Pharma committed to tiered pricing' for India, says MD Shweta Rai

Business Line

Bayer plans to fast-track innovation and localise global products in India: Rai

Pharmaceuticals & Biotech.

SECTOR | 03 Jun 2025

Top Conviction Ideas - Pharmaceutical & Hospitals

Pharmaceuticals & Biotech.

Axis Direct

Top Conviction Ideas - Lupin Ltd, Aurobindo Pharma Ltd, Max Healthcare Institute Ltd, Fortis Healthcare Ltd.

Pharmaceuticals & Biotech.

SECTOR | 01 Jun 2025

Global meet on medical devices

Business Line

Geneva to host WHO Global Forum on Medical Devices

Pharmaceuticals & Biotech.

SECTOR | 31 May 2025

TDB backs India's first indigenous stroke treatment device manufacturing

Business Line

The company will establish an integrated manufacturing plant at the Medical Devices Park in Oragadam, Chennai, to produce mechanical thrombectomy kits used for treating acute ischemic stroke

Pharmaceuticals & Biotech.

SECTOR | 26 May 2025

Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug

Business Standard

Biocon share rose after arm, Biocon Biologics, was granted market authorisation in the UK for Yesintek, a biosimilar of Ustekinumab, from the Medicines and Healthcare products Regulatory Agency (MHRA)

Pharmaceuticals & Biotech.

SECTOR | 20 May 2025

Pfizer Share Price Surges After Q4 Profit Jumps, Margin Improves

NDTV Profit

In February, Pfizer had signed a sales and marketing pact with Mylan Pharmaceuticals Pvt.

Pharmaceuticals & Biotech.

SECTOR | 19 May 2025

WHO opens annual meet amid crisis sparked by US funding cuts, exit plans

Business Standard

The World Health Organisation on Monday opened its annual meeting of government ministers and other top envoys facing one of the most serious crises of its 77-year history in the wake of Trump administration funding cuts and plans to withdraw the United States. The UN health agency this year has seen a plunge in its ability to carry out its sweeping mandate to do everything from recommend reductions in sugar levels in soft drinks to head the global response to pandemics like COVID-19 or outbreaks like polio or Ebola. Director-General Tedros Adhanom Ghebreyesus has been grappling with a response to the US cuts as well as reduced outlays from other traditional Western donors who are putting more money toward defense and less toward humanitarian aid. Matthew Kavanagh, the director of Georgetown University's centre for Global Health Policy and Politics, said other countries have used the US disruption the cut in aid as cover to do their maneuvering, with many countries in Europe...